Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0188) — Grand Island, Nebraska

Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0188) is a clinical research site located in Grand Island, Nebraska, United States 68803.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0188) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: DLBCL, Diffuse Large B-Cell Lymphoma.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0188)?

Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0188) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0188) conducted?

Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0188) has 1 clinical trials on record, with 1 currently active. Their work covers DLBCL, Diffuse Large B-Cell Lymphoma.

Is Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0188) accredited by Crixeo Health?

Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0188) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0188)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.